-- 
BioSante, CVR Energy, H&E, Sigma Designs: U.S. Equity Movers

-- B y   L u   W a n g
-- 
2011-03-03T21:37:20Z

-- http://www.bloomberg.com/news/2011-03-02/chiquita-general-dynamics-greif-opka-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in  New York .  Acacia Research (ACTG US) rallied 16 percent to $33.93, the
highest price since at least December 2002. The owner of
technology patents resolved patent matters with Samsung
Electronics Co., according to a regulatory filing.    America Service Group Inc. (ASGR)   surged 47 percent, the
most intraday since its initial public offering in November
1991, to $25.65. The health-care provider for U.S. prisons
agreed to be bought by Valitas Health Services Inc. for $26 a
share. America Service plans to seek superior proposals for 45
days.    Amylin Pharmaceuticals Inc. (AMLN)   and  Alkermes Inc. (ALKS) 
 fell after the companies’ diabetes drug Bydureon
didn’t control the disease better than Novo Nordisk A/S’ Victoza
in a study.  Amylin Pharmaceuticals plunged 25 percent to $11.20 for the
biggest retreat in the Russell 1000 Index. Alkermes dropped 11
percent to $12.56.    BioSante Pharmaceuticals Inc. (BPAX)   gained 5.9 percent
to $2.15, the first increase in three days. The developer of
hormone-replacement products said its pancreas cancer vaccine
increased survival rate by more than 25 percent in a study.    Central European Media Enterprises Ltd. (CETV)   rose 6.7
percent to $20.68, the highest price since Jan. 7. Time Warner
Inc. (TWX US) increased its stake in the broadcaster known as
CME to 34.4 percent after buying 3.1 million shares yesterday,
according to a regulatory filing.    China New Borun Corp. (BORN)   jumped 12 percent to $13.25
for the biggest gain since Jan. 24. The supplier of grain
alcohol to makers of the country’s traditional spirits forecast
first-quarter sales of $82 million at least. That beat Cowen &
Co.’s estimate of $78.4 million.    Coventry Health Care Inc. (CVH)   had the fourth-biggest
gain in the  Standard & Poor’s 500  Index, adding 5.7 percent to
$32.30. The managed health-care company was raised to “buy”
from “hold” at Stifel Nicolaus & Co.    CVR Energy Inc. (CVI)   rose 8.4 percent, the most since
Nov. 2, to $20.42. The  Sugar Land , Texas-based oil refiner
reported fourth-quarter sales of $1.15 billion, topping the
average estimate of $1.04 billion from two analysts in a
Bloomberg survey.    Fuel Systems Solutions Inc. (FSYS)   slid 11 percent, the
most since June 2009, to $24.80. The provider of alternative
fuel systems forecast 2011 sales of $400 million at most,
trailing the average analyst estimate of $402.4 million,
Bloomberg data show.    Global Defense Technology & Systems Inc. (GTEC)   rose the
most in the Russell 2000 Index, rallying 51 percent to $24.25.
The maker of counter-terrorism systems agreed to be bought by
Ares Management LLC for $24.25 a share.    H&E Equipment Services Inc. (HEES)   climbed 16 percent,
the most since March 2009, to $18.64. The  Baton Rouge ,
Louisiana-based company that rents and sells construction
equipment posted an adjusted fourth-quarter loss of 7 cents a
share, narrower than the average analyst estimate of 16 cents
from a Bloomberg survey.    LHC Group Inc. (LHCG)   declined 6.9 percent, the most
since July 1, to $27.98. The provider of rural health-care
services reported fourth-quarter earnings of 63 cents a share
excluding some items, missing the average analyst estimate by
4.8 percent. LHC was cut to “hold” from “buy” at Jefferies &
Co. Inc. The 12-month price estimate is $26.  Motorola Mobility Holdings Inc. (MMI US) slipped 5.6
percent to $26.78, the biggest decline in the Standard & Poor’s
500. The mobile-phone maker was cut to “neutral” from
“outperform” by Cowen & Co. analyst  Matthew Hoffman , who cited
competition for the company’s XOOM tablet from Apple Inc.’s iPad
2, being introduced next week.  Opka Health Inc. (OPK US) declined 7.6 percent, the most
since Aug. 11, to $4.25. The Miami-based drugmaker announced an
offering of $100 million of stock.        Radio One Inc. (ROIAK)   dropped 11 percent, the most
since Nov. 23, to $1.92. The operator of AM and FM stations
reported a fourth-quarter net loss of 52 cents a share.    Sauer-Danfoss Inc. (SHS)   soared 33 percent, the most
since at least May 1998, to $40.18. The maker of mobile
hydraulic systems forecast 2011 earnings of at least $3 a share
and sales to grow more than 10 percent.    Sigma Designs Inc. (SIGM)   dropped 13 percent, the most
since August 2009, to $11.91. The maker of processors for
Internet television set-top boxes and Blu-ray video players
forecast first-quarter sales of $65 million at most. Analysts,
on average, had estimated $67.6 million, according to a
Bloomberg survey.        Teradata Corp. (TDC)   climbed 6.3 percent to $50.55, the
highest price since at least September 2007. The data-storage  software company  said it agreed to buy the 89 percent of Aster
Data Systems Inc. that it doesn’t own for $263 million.    Valero Energy Corp. (VLO)   advanced the most in the  S&P
500 , climbing 7.7 percent to $28.98. The independent U.S.
refiner said it expects to earn as much as 30 cents a share in
the first quarter, after recording a loss of $348 million on
forward sales of refined products. That the company has closed
out the positions “removes a negative,” Credit Suisse Group AG
said in a note.  Tesoro Corp. (TSO)   rose 7.5 percent to
$25.10.  Wendy’s/Arby’s Group Inc. (WEN US) jumped 7.7 percent, the
most since June 2009, to $5.10. The third-biggest U.S. hamburger
chain said a possible sale of the Arby’s brand would increase
earnings and free  cash flow .    Zumiez Inc. (ZUMZ)   added 5.5 percent, the most since
Jan. 26, to $27.36. The retailer based in Everett,  Washington ,
said February comparable sales increased 12.8 percent, more than
the average analyst estimate of a 3.2 percent rise.  To contact the reporter on this story:
Lu Wang in New York at 
 lwang8@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  